Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2018

Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era
Authors: D. ZIDEKOVA, I. WACZULIKOVA, L. DOLESOVA, L. VAVROVA, O. HAMIDOVA, R. LOHAJOVA BEHULOVA, M. KONECNY
Neoplasma Vol.65, No.2, p.309-315, 2018
doi:10.4149/neo_2018_170507N328
[View Abstract]


Neurotropism as a prognostic factor in cutaneous melanoma patients
Authors: F. TAS, K. ERTURK
Neoplasma Vol.65, No.2, p.304-308, 2018
doi:10.4149/neo_2018_170426N312
[View Abstract]


Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis – long-term experience from a single center
Authors: M. PALOVA, T. SZOTKOWSKI, A. HLUSI, K. INDRAK, J. NAVRATILOVA, M. DIVOKA, T. PAPAJIK
Neoplasma Vol.65, No.2, p.296-303, 2018
doi:10.4149/neo_2018_170426N313
[View Abstract]


Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma
Authors: X. SHI, X. CHEN, W. C. LI, L. J. MO, Z. Y. LIN, Y. Y. LI, Z. YANG, W. N. MO
Neoplasma Vol.65, No.2, p.292-295, 2018
doi:10.4149/neo_2018_170318N194
[View Abstract]


Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery
Authors: M. STANIK, A. POPRACH, D. MACIK, I. CAPAK, D. MALUSKOVA, N. MARECKOVA, R. LAKOMY, J. JARKOVSKY, J. DOLEZEL
Neoplasma Vol.65, No.2, p.287-291, 2018
doi:10.4149/neo_2018_170403N239
[View Abstract]


Mucosal and skin HPV types in tumour-free tonsils and tonsillar tumours
Authors: M. SALAKOVA, E. KOSLABOVA, M. GREGA, J. SMAHELOVA, J. KLOZAR, O. VENCALEK, R. TACHEZY
Neoplasma Vol.65, No.2, p.278-286, 2018
doi:10.4149/neo_2018_170314N179
[View Abstract]


Value of two-cycle docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy in hypopharyngeal carcinoma
Authors: X. LUO, B. ZHANG, Z. LIAN, Y. DONG, J. LIU, S. PEI, X. MO, L. ZHANG, W. HUANG, F. OUYANG, B. GUO, C. LIANG, S. ZHANG
Neoplasma Vol.65, No.2, p.269-277, 2018
doi:10.4149/neo_2018_170213N102
[View Abstract]


Change in FGF-2 circulating levels after arterial embolization in patients with bone metastases
Authors: G. ROSSI, M. SALERNO, D. GRANCHI, E. CENNI, G. FACCHINI, N. BALDINI
Neoplasma Vol.65, No.2, p.262-268, 2018
doi:10.4149/neo_2018_170204N74
[View Abstract]


An extensive study of the mechanism of prostate cancer metastasis
Authors: Y. WANG, W. GUO, H. XU, X. ZHU, T. YU, Z. JIANG, Q. JIANG, X. GANG
Neoplasma Vol.65, No.2, p.253-261, 2018
doi:10.4149/neo_2018_161217N648
[View Abstract]


Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma
Authors: F. WU, S. WU, X. GOU
Neoplasma Vol.65, No.2, p.242-252, 2018
doi:10.4149/neo_2018_170511N342
[View Abstract]


Urinary fluorescence analysis in diagnosis of bladder cancer
Authors: B. KOLLARIK, M. ZVARIK, P. BUJDAK, P. WEIBL, L. RYBAR, L. SIKUROVA, L. HUNAKOVA
Neoplasma Vol.65, No.2, p.234-241, 2018
doi:10.4149/neo_2018_170610N420
[View Abstract]


Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment
Authors: C. X. ZHU, W. Z. LI, Y. L. GUO, L. CHEN, G. H. LI, J. J. YU, B. SHU, S. PENG
Neoplasma Vol.65, No.2, p.228-233, 2018
doi:10.4149/neo_2018_170203N72
[View Abstract]


Cisplatin binds to pre-miR-200b and impairs its processing to mature microRNA
Authors: R. MEZENCEV, R. M. WARTELL
Neoplasma Vol.65, No.2, p.222-227, 2018
doi:10.4149/neo_2018_170116N37
[View Abstract]


Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis
Authors: T. DENG, X. DUAN, B. LIU, Y. LAN, C. CAI, T. ZHANG, W. ZHU, Z. MAI, W. WU, G. ZENG
Neoplasma Vol.65, No.2, p.216-221, 2018
doi:10.4149/neo_2018_170111N23
[View Abstract]


Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro
Authors: M. FIORENTZIS, H. KALIRAI, P. KATOPODIS, B. SEITZ, A. VIESTENZ, S. E. COUPLAND
Neoplasma Vol.65, No.2, p.210-215, 2018
doi:10.4149/neo_2018_170329N227
[View Abstract]


The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation
Authors: X. CHEN, X. Y. LI, M. LONG, X. WANG, Z. W. GAO, Y. CUI, J. REN, Z. ZHANG, C. LIU, K. DONG, H. ZHANG
Neoplasma Vol.65, No.2, p.201-209, 2018
doi:10.4149/neo_2018_170228N149
Price: free access
[View Abstract]


MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor
Authors: Z. QI, B. ZHANG, J. ZHANG, Q. HU, F. XU, B. CHEN, C. ZHU
Neoplasma Vol.65, No.2, p.192-200, 2018
doi:10.4149/neo_2018_170217N118
[View Abstract]


Ste20-like kinase is upregulated in glioma and induces glioma invasion
Authors: K. WANG, R. L. HONG, J. B. LU, D. L. WANG
Neoplasma Vol.65, No.2, p.185-191, 2018
doi:10.4149/neo_2018_170318N193
[View Abstract]


The association between LncRNA HOTAIR and cancer lymph node metastasis and distant metastasis: a meta-analysis
Authors: Z. SUN, X. Y. WU, C. L. WU
Neoplasma Vol.65, No.2, p.178-184, 2018
doi:10.4149/neo_2018_170114N34
[View Abstract]


Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells
Authors: J. WU, H. ZHANG, W. ZHANG, J. ZHANG, X. LIN, G. XUE, F. GAO
Neoplasma Vol.65, No.2, p.169-177, 2018
doi:10.4149/neo_2018_170119N51
[View Abstract]





Display #  
Results 61 - 80 of 100

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.